The DOI matches its Crossref record; 314 of the 314 references it cites were found in a registry or an index.
Inflammatory cell infiltration of tumors: Jekyll or Hyde
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–314 of 314
Sandel, M. H., Dadabayev, A. R., Menon, A. G., Morreau, H., Melief, C. J. M., Offringa, R., van der Burg, S. H., Janssen-van Rhijn, C. M., Ensink, N. G., Tollenaar, R. A. E. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1448 · Cited by 173
Ohno, S., Inagawa, H., Dhar, D. K., Fujii, T., Ueda, S., Tachibana, M., Suzuki, N., Inoue, M., Soma, G., & Nagasue, N. (2003) · PubMed · Cited by 171
Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.
Seung, L. P., Rowley, D. A., Dubey, P., & Schreiber, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6254 · Cited by 170
Malmberg, K. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0577-x · Cited by 169
Differential Effects of IL-1α and IL-1β on Tumorigenicity Patterns and Invasiveness
Song, X., Voronov, E., Dvorkin, T., Fima, E., Cagnano, E., Benharroch, D., Shendler, Y., Bjorkdahl, O., Segal, S., Dinarello, C. A., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6448 · Cited by 169
Variegation of the Immune Response with Dendritic Cells and Pathogen Recognition Receptors
Pulendran, B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2457 · Cited by 169
Dendritic cell trafficking: More than just chemokines
Sozzani, S. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.04.008 · Cited by 168
Piras, F., Colombari, R., Minerba, L., Murtas, D., Floris, C., Maxia, C., Corbu, A., Perra, M. T., & Sirigu, P. (2005) · Cancer · doi:10.1002/cncr.21283 · Cited by 168
Molecular Mechanisms of Breast Cancer Metastases to Bone
Guise, T. A., Kozlow, W. M., Heras-Herzig, A., Padalecki, S. S., Yin, J. J., & Chirgwin, J. M. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.s.004 · Cited by 167
GM-CSF-secreting melanoma vaccines
Dranoff, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206459 · Cited by 166
Shurin, M. R., Shurin, G. V., Lokshin, A., Yurkovetsky, Z. R., Gutkin, D. W., Chatta, G., Zhong, H., Han, B., & Ferris, R. L. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9010-6 · Cited by 163
Bromwich, E. J., McArdle, P. A., Canna, K., McMillan, D. C., McNicol, A.-M., Brown, M., & Aitchison, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601400 · Cited by 162
Reichert, T. E., Scheuer, C., Day, R., Wagner, W., & Whiteside, T. L. (2001) · Cancer · doi:10.1002/1097-0142(20010601)91:11<2136::aid-cncr1242>3.0.co;2-q · Cited by 162
Koide, N., Nishio, A., Sato, T., Sugiyama, A., & Miyagawa, S.-I. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30733.x · Cited by 158
Strasly, M., Cavallo, F., Geuna, M., Mitola, S. M. F., Colombo, M. P., Forni, G., & Bussolino, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3890 · Cited by 156
Fujimoto, J., Sakaguchi, H., Aoki, I., & Tamaya, T. (2000) · PubMed · Cited by 154
Thörn, M., Ponte, F., Bergström, R., Sparén, P., & Adami, H. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.10.761 · Cited by 154
Ardavín, C., Amigorena, S., & Sousa, C. R. E. (2004) · Immunity · doi:10.1016/s1074-7613(03)00352-2 · Cited by 149
Lathers, D. M. R., Clark, J. I., Achille, N. J., & Young, M. R. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0459-7 · Cited by 149
Chang, C.-C. J., Wright, A., & Punnonen, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3584 · Cited by 149
Gollob, J., Veenstra, K. G., Parker, R. A., Mier, J. W., McDermott, D. F., Clancy, D., Tutin, L., Koon, H. B., & Atkins, M. B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.119 · Cited by 148
Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer
Triozzi, P. L., Khurram, R., Aldrich, W. A., Walker, M. J., Kim, J. A., & Jaynes, S. (2000) · Cancer · doi:10.1002/1097-0142(20001215)89:12<2646::aid-cncr18>3.0.co;2-a · Cited by 147
Fidler, I. J., & Talmadge, J. E. (1986) · PubMed · Cited by 145
Self-citationPotential cardioprotective actions of no-releasing aspirin
Wallace, J. L., Ignarro, L. J., & Fiorucci, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd794 · Cited by 144
Egilmez, N. K., Jong, Y. S., Sabel, M. S., Jacob, J. S., Mathiowitz, E., & Bankert, R. B. (2000) · PubMed · Cited by 143
Saito, H., Tsujitani, S., Ikeguchi, M., Maeta, M., & Kaibara, N. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.725 · Cited by 142
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
Talmadge, J. E., Hood, K. C., Zobel, L., Shafer, L. R., Coles, M., & Tóth, B. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.09.021 · Cited by 139
Self-citationIL-12 regulates VEGF and MMPs in a murine breast cancer model
Dias, S., Boyd, R., & Balkwill, F. R. (1998) · International Journal of Cancer · Cited by 137
Papillary Carcinoma of the Thyroid
Scarpino, S., Stoppacciaro, A., Ballerini, F., Marchesi, M., Prat, M., Stella, M. C., Sozzani, S., Allavena, P., Mantovani, A., & Ruco, L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64951-6 · Cited by 135
Morris, E. S., MacDonald, K. P. A., Rowe, V., Johnson, D., Banovic, T., Clouston, A. D., & Hill, G. R. (2004) · Blood · doi:10.1182/blood-2003-08-2864 · Cited by 134
Down-Regulation of HLA-A Expression Correlates with a Better Prognosis in Colorectal Cancer Patients
Menon, A. G., Morreau, H., Tollenaar, R. A. �. �., Alphenaar, E. A., van Puijenbroek, M., Putter, H., Rhijn, C. M. J., van de Velde, C. J. �., Fleuren, G. J., & Kuppen, P. J. K. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000043124.75633.ed · Cited by 131
Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
Tsung, K., Dolan, J. P., Tsung, Y. L., & Norton, J. A. (2002) · PubMed · Cited by 129
Candido, K. A., Shimizu, K., McLaughlin, J. C., Kunkel, R., Fuller, J. A., Redman, B. G., Thomas, E. K., Nickoloff, B. J., & Mulé, J. J. (2001) · PubMed · Cited by 124
RANTES expression is a predictor of survival in stage I lung adenocarcinoma.
Moran, C. J., Arenberg, D. A., Huang, C. C., Giordano, T. J., Thomas, D. G., Misek, D. E., Chen, G., Iannettoni, M. D., Orringer, M. B., Hanash, S., et al. (2002) · PubMed · Cited by 124
Non‐steroidal anti‐inflammatory drugs for the prevention and treatment of cancer
Pereg, D., & Lishner, M. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01519.x · Cited by 123
Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8
Feijoó, E., Alfaro, C., Mazzolini, G. D., Serra, P., Peñuelas, I., Arina, A., Huarte, E., Tirapu, I., Palencia, B., Murillo, O., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21046 · Cited by 122
Gervois, N., Guilloux, Y., Diez, E., & Jotereau, F. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2403 · Cited by 122
Tong, Y., Song, W., & Crystal, R. G. (2001) · PubMed · Cited by 118
Takahashi, A., Kono, K., Ichihara, F., Sugai, H., Fujii, H., & Matsumoto, Y. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0466-8 · Cited by 117
Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma
Suzuki, A., Masuda, A., Nagata, H., Kameoka, S., Kikawada, Y., Yamakawa, M., & Kasajima, T. (2001) · The Journal of Pathology · doi:10.1002/path.1018 · Cited by 117
Koukourakis, M., Giatromanolaki, A. N., Kakolyris, S., O'Byrne, K. J., Apostolikas, N., Skarlatos, J., Gatter, K., & Harris, A. L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.280 · Cited by 116
Shaping the immune response to parasites: role of dendritic cells
Sher, A., Pearce, E. J., & Kaye, P. M. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00072-4 · Cited by 113
The Biology of Melanoma Brain Metastasis
Fidler, I. J., Schackert, G., Zhang, R.-D., Radinsky, R., & Fujimaki, T. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006329410433 · Cited by 112
Tumor-Associated Macrophages as Targets for Cancer Therapy
Wahl, L. M., & Kleinman, H. K. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1583 · Cited by 110
Reed, J. A., McNutt, N. S., Prieto, V. G., & Albino, A. P. (1994) · PubMed Central · Cited by 110
Gualandris, A., Rusnati, M., Bastaki, M., Ziche, M., & Presta, M. (1998) · Springer eBooks · doi:10.1007/978-1-4899-0133-0_30 · Cited by 109
Mroczko, B., Groblewska, M., Wereszczyńska-Siemiątkowska, U., Okulczyk, B., Kędra, B., Łaszewicz, W., Dâbrowski, A., & Szmitkowski, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.037 · Cited by 108
Okazaki, T., Ebihara, S., Asada, M., Kanda, A., Sasaki, H., & Yamaya, M. (2005) · International Immunology · doi:10.1093/intimm/dxh334 · Cited by 104
Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma.
Hamada, I., Kato, M., Yamasaki, T., Iwabuchi, K., Watanabe, T., Yamada, T., Itoyama, S., Ito, H., & Okada, K. (2002) · PubMed · Cited by 101
Kerkelä, E., Ala‐aho, R., Klemi, P. J., Grénman, S., Shapiro, S. D., Kähäri, V., & Saarialho‐Kere, U. (2002) · The Journal of Pathology · doi:10.1002/path.1198 · Cited by 101
Preynat‐Seauve, O., Schuler, P., Contassot, E., Beermann, F., Huard, B., & French, L. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.61 · Cited by 100
Inoshima, N., Nakanishi, Y., Minami, T., Izumi, M., Takayama, K., Yoshino, I., & Hara, N. (2002) · PubMed · Cited by 99
Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H
Blasius, A. L., & Colonna, M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.04.005 · Cited by 96
Macrophage content of metastatic and nonmetastatic rodent neoplasms.
Talmadge, J. E., Key, M. E., & Fidler, I. J. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.6.2245 · Cited by 95
Self-citationAngiogenesis and inflammation in invasive carcinoma of the breast.
Lee, A. H., Happerfield, L. C., Bobrow, L. G., & Millis, R. R. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.8.669 · Cited by 95
Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers
Young, M. R., & Lathers, D. M. R. (1999) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(99)00008-9 · Cited by 95
Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and Invasion
Singh, S., Singh, U. P., Stiles, J. K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0266 · Cited by 94
Inhibition of CD40 expression and CD40‐mediated dendritic cell function by tumor‐derived IL‐10
Shurin, M. R., Yurkovetsky, Z. R., Tourkova, I. L., Balkir, L., & Shurin, G. V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10576 · Cited by 92
van Herpen, C. M., Looman, M. W. G., Zonneveld, M. I., Scharenborg, N. M., de Wilde, P. C., van de Locht, L. T., Merkx, M. A. W., Adema, G. J., & de Mulder, P. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0304 · Cited by 92
Porta, M. G. D., Danova, M., Rigolin, G. M., Brugnatelli, S., Rovati, B., Tronconi, M. C., Fraulini, C., Rossi, A. R., Riccardi, A., & Castoldi, G. (2005) · Oncology · doi:10.1159/000086784 · Cited by 91
Lamb, D. J., Modjtahedi, H., Plant, N. J., & Ferns, G. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.012 · Cited by 84
Tumor Angiogenesis Induced by Granulocyte Chemotactic Protein-2 as a Countercurrent Principle
Coillie, E. V., Aelst, I. V., Wuyts, A., Vercauteren, R., Devos, R., Wolf‐Peeters, C. D., Damme, J. V., & Opdenakker, G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62527-8 · Cited by 83
THE SIGNIFICANCE OF MACROPHAGES IN HUMAN AND EXPERIMENTAL TUMORS*
Alexander, P. M., Eccles, S. A., & Gauci, C. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb41641.x · Cited by 83
IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Ménétrier‐Caux, C., Thomachot, M. C., Alberti, L., Montmain, G., & Blay, J. (2001) · PubMed · Cited by 83
Wesa, A. K., & Galy, A. H. M. (2002) · BMC Immunology · doi:10.1186/1471-2172-3-14 · Cited by 83
Watanabe, T., Kawano, Y., Kanamaru, S., Onishi, T., Kaneko, S., Wakata, Y., Nakagawa, R., Makimoto, A., Kuroda, Y., Takaue, Y., et al. (1999) · Blood · doi:10.1182/blood.v93.4.1157 · Cited by 82
Self-citationCycloxygenase-2 Inhibition Augments the Efficacy of a Cancer Vaccine
Haas, A. R., Sun, J., Vachani, A., Wallace, A. F., Silverberg, M. B., Kapoor, V., & Albelda, S. Μ. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1178 · Cited by 82
Key, M. E., Talmadge, J. E., Fogler, W. E., Bucana, C. D., & Fidler, I. J. (1982) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/69.5.1189 · Cited by 80
Self-citationParajuli, P., Mosley, R. L., Писарев, В. М., Chavez, J. M., Ulrich, A., Varney, M. L., Singh, R. K., & Talmadge, J. E. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00722-6 · Cited by 80
Self-citationThe mononuclear cell infiltrate compared with survival in high-grade astrocytomas
Rossi, M. I., Jones, N., Candy, E., Nicoll, J. A. R., Compton, J. S., Hughes, J. T., Esiri, M. M., Moss, T., Cruz-Sánchez, F. F., & Coakham, H. B. (1989) · Acta Neuropathologica · doi:10.1007/bf00688208 · Cited by 78
Gambotto, A. A., Tüting, T., McVey, D., Kovesdi, I., Tahara, H., Lotze, M. T., & Robbins, P. D. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700013 · Cited by 78
Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma
Tang, T. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i13.1896 · Cited by 77
Interleukin-12 enhances peripheral hematopoiesis in vivo
Jackson, J., Yan, Y., Brunda, M., et al. (1995) · Blood · doi:10.1182/blood.v85.9.2371.bloodjournal8592371 · Cited by 75
Cytokine Gene Therapy of Cancer Using Interleukin‐12: Murine and Clinical Trials
Lotze, M. T., Zitvogel, L., Campbell, R. L., Robbins, P. D., Elder, E. M., Haluszczak, C., Martin, D. M., Whiteside, T. L., Storkus, W. J., & Tahara, H. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52715.x · Cited by 74
Kemp, T. J., Elzey, B. D., & Griffith, T. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.212 · Cited by 73
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Duval, D. L., Miller, D. R., Collier, J., & Billings, R. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09220-x · Cited by 69
Regulation of Interleukin-8 Expression by Tumor-Associated Stress Factors
Shi, Q., Xiong, Q., Le, X., & Xie, K. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900152547812 · Cited by 68
Sun, X., & Zhang, H. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-43 · Cited by 68
Cyclooxygenase 2 Inhibition Promotes IFN-γ-Dependent Enhancement of Antitumor Responses
Sharma, S. P., Zhu, L. X., Yang, S.-C., Zhang, L., Lin, J. F.-H., Hillinger, S., Gardner, B. K., Reckamp, K. L., Strieter, R. M., Huang, M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.813 · Cited by 68
CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer
Coventry, B. J., & Morton, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601114 · Cited by 67
Bv, S. (1976) · PubMed · Cited by 66
Varney, M. L., Olsen, K. J., Mosley, R. L., Bucana, C. D., Talmadge, J. E., & Singh, R. K. (2002) · PubMed · Cited by 63
Self-citationSpadaro, M., Ambrosino, E., Iezzi, M., Carlo, E. D., Sacchetti, P., Curcio, C., Amici, A. R. D., Wei, W., Musiani, P., Lollini, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1873 · Cited by 63
Miyagawa, S., Soeda, J., Takagi, S., Miwa, S., Ichikawa, E., & Noike, T. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.07.018 · Cited by 60
Interleukin 13: A Growth Factor in Hodgkin Lymphoma
Skinnider, B., Kapp, U., & Mak, T. W. (2001) · International Archives of Allergy and Immunology · doi:10.1159/000049523 · Cited by 59
Tímár, J., Ladányi, A., Forster‐Horváth, C., Lukits, J., Döme, B., Remenár, É., Gődény, M., Kásler, M., Bencsik, B., Répássy, G. D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.005 · Cited by 59
Jost, M. M., Ninci, E., Meder, B., Kempf, C., van Royen, N., Hua, J., Berger, B. J., Hoefer, I. E., Modolell, M., & Buschmann, I. R. (2003) · The FASEB Journal · doi:10.1096/fj.03-0071fje · Cited by 59
IL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production
Mitola, S., Strasly, M., Prato, M., Ghia, P., & Bussolino, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3725 · Cited by 58
Thomachot, M. C., Bendriss‐Vermare, N., Massacrier, C., Biota, C., Treilleux, I., Goddard‐Léon, S., Caux, C., Bachelot, T., Blay, J., & Ménétrier‐Caux, C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20146 · Cited by 58
Young, M. R., Wright, M. A., & Young, M. E. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01756134 · Cited by 57
Reduction of tumour cell entry into vessels by BCG-activated macrophages
Liotta, L. A., Gattozzi, C., Kleinerman, J. I., et al. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.242 · Cited by 56
Stromal-cell regulation of dendritic-cell differentiation and function
Svensson, M., & Kaye, P. M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.006 · Cited by 56
Holda, J. H., MAIER, T., & Claman, H. N. (1985) · Immunological Reviews · doi:10.1111/j.1600-065x.1985.tb01154.x · Cited by 56
Partial regression in primary carcinoma of the lung: does it occur?
Kerr, K. M., Johnson, S. K., King, G., Kennedy, M., Weir, J., & Jeffrey, R. R. (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00453.x · Cited by 55
Tumour-associated macrophages in breast cancer and their prognostic correlations
Volodko, N., Reiner, A., Rudas, M., & Jakesz, R. (1998) · The Breast · doi:10.1016/s0960-9776(98)90065-0 · Cited by 53
Guermonprez, P., Fayolle, C., Rojas, M.-J., Rescigno, M., Ladant, D., & Leclerc, C. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3071::aid-immu3071>3.0.co;2-a · Cited by 53
Embleton, M. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601103 · Cited by 51
Kanai, T., Watanabe, M., Hibi∥, T., Hayashi, A., Nakazawa, A., Yajima, T., Okazawa, A., YAMAZAKI, M., & Ishii, H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1113 · Cited by 50
Kolbeck, P. C., Kaveggia, F. F., Johansson, S. L., Grune, M. T., & Taylor, R. J. (1992) · PubMed · Cited by 50
Angulo, I., Rullás, J., Campillo, J. A., Obregón, E., Heath, A. W., Howard, M., Muñoz‐Fernández, M. Á., & Subiza, J. L. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200005)30:5<1263::aid-immu1263>3.0.co;2-5 · Cited by 47
Macrophages and Microvessel Density in Tumors of the Ovary
Orre, M., & Rogers, P. A. W. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5292 · Cited by 47
Tumor microvasculature as a barrier to antitumor immunity
Chen, Q., Wang, W., & Evans, S. S. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0425-4 · Cited by 45
Mooradian, D. L., Purchio, A. F., & Furcht, L. T. (1990) · PubMed · Cited by 43
Roy, K. C., Bandyopadhyay, G. K., Rakshit, S., Ray, M., & Bandyopadhyay, S. K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01162 · Cited by 42
Vakkila, J., Thomson, A. W., Vettenranta, K. K., Sariola, H. V., & Saarinen-Pihkala, U. M. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02388.x · Cited by 39
Fidler, I. J., Roblin, R. O., & Poste, G. H. (1978) · Cellular Immunology · doi:10.1016/0008-8749(78)90039-4 · Cited by 38
Iizasa, H., Yoneyama, H., Mukaida, N., Katakoka, Y., Naito, M., Yoshida, N., Nakashima, E., & Matsushima, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3273 · Cited by 36
Solheim, J. C., Reber, A. J., Ashour, A. E., Robinson, S., Futakuchi, M., Kurz, S. G., Hood, K. C., Fields, R. R., Shafer, L. R., Cornell, D., et al. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701018 · Cited by 36
Self-citationVicioso, L., Gonzalez, F. J., Alvarez, M., Ribelles, N., Molina, M., Márquez, A., Pérez, L. M. G., Matilla, A., & Alba, E. (2005) · American Journal of Clinical Pathology · doi:10.1309/0864af2u3lgpcf3j · Cited by 31
Expression of the Chemokines IP-10 and Mig in IL-10 Transduced Tumors
Sun, H., Kundu, N., Dorsey, R. M., Jackson, M. J., & Fulton, A. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00008 · Cited by 25
Romanelli, M. M. C., Maes, H. H., Wasserman, K., et al. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00085-9 · Cited by 21
Inoue, Y., Nakayama, Y., Minagawa, N., Katsuki, T., Nagashima, N., Matsumoto, K., Shibao, K., Tsurudome, Y., Hirata, K., Nagata, N., et al. (2005) · PubMed · Cited by 19
Key, M. E., Talmadge, J. E., & Fidler, I. J. (1982) · PubMed · Cited by 17
Self-citation
Cited by
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
“For example, infiltration of CD8 + T cells and mature dendritic cells is associated with a favourable prognosis in colorectal cancer and head and neck cancer (reviewed in Ref”
BackgroundMacrophage Polarization States in the Tumor Microenvironment
Boutilier, A. J., & Elsawa, S. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136995 · Cited by 1,631
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Metadata
- Authors
- Talmadge, J. E., Donkor, M., & Scholar, E.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2007-08-24
- Volume
- 26
- Issue
- 3-4
- Pages
- 373-400
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2058755650
- Cited by
- 313
- References
- 314
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.